Lorven Biologics - About the company
Lorven Biologics is a seed company based in Hyderabad (India), founded in 2015 by Amal Mukhopadhyay. It operates as a Developer of nutritional and pharma products. Lorven Biologics has raised $46.6K in funding from KIIT-TBI, with a current valuation of ₹*****. The company has 430 active competitors, including 132 funded and 65 that have exited. Its top competitors include companies like Ginkgo Bioworks, Syngenta and Synthego.
Company Details
Lorven Biologics develops and manufactures nutritional and pharma products. The biopharma products of the company include various APIs such as liraglutide, teriparatide, teduglutide, snake venom detection kit, etc. They also offer agriculture and veterinary livestock products.
- Website
- lorvenbiologics.com
- Social
- Email ID
- *****@lorvenbiologics.com
- Phone Number
- +91 **********
- Registered Address
- Modugulapeta Village,Govindapuram Post Santhakavitri Mandal, Srikakulam, Andhra Pradesh, India, 532123
Legal entities associated with Lorven Biologics
Lorven Biologics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
LORVEN BIOLOGICS PRIVATE LIMITED CIN: U74120AP2015PTC097532 , India, Active | Oct 09, 2015 | $2.28M (As on Mar 31, 2025) | 34 (As on Nov 30, 2024) |
Sign up to download Lorven Biologics' company profile
Lorven Biologics's funding and investors
Lorven Biologics has raised a total funding of $46.6K over 1 round. Its latest funding round was a Seed round on Jul 16, 2017 for $*****. 1 investor participated in its latest round. Lorven Biologics has 3 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of Lorven Biologics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 16, 2017 | 9588465 | Seed | 6195656 | 2778678 | 4663686 | 4762984 |
Access funding benchmarks and valuations. Sign up today!View details of Lorven Biologics's funding rounds and investors
Lorven Biologics' founders and board of directors
Founder? Claim ProfileThe founders of Lorven Biologics is Amal Mukhopadhyay.
Here are the details of Lorven Biologics' key team members:
- Amal Mukhopadhyay: Co-Founder and Managing Director of Lorven Biologics.
Lorven Biologics' Board of Directors
Lorven Biologics's board has 4 active members. Venkataramana Mudili and Devi Kalyan Kumar Thakasi are part of team and Rahul Kumar Peraka and Srikanth Reddy Devireddy are independent board members.Here is the list of Lorven Biologics' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 4y 8m | |
sayujoc | Team | - | Current | 8y 5m |
Independent board member | - | Current | 5y 2m | |
ntst{ka | Independent board member | - | Current | 2y 5m |
xwznesh | Independent board member | - | Past | 8y 1m |
posieuf | Independent board member | - | Past | 8y 7m |
vzmtewc | Independent board member | - | Past | 8y 7m |
View details of Lorven Biologics's Founder profiles and Board Members
Lorven Biologics' employee count trend
Lorven Biologics has 34 employees as of Apr 26. Here is Lorven Biologics's employee count trend over the years:
Uncover Lorven Biologics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Lorven Biologics's Competitors and alternates
Top competitors of Lorven Biologics include Ginkgo Bioworks, Syngenta and Synthego. Here is the list of Top 10 competitors of Lorven Biologics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Ginkgo Bioworks 2008, Boston (United States), Public | Autonomous labs for biotechnology, empowering scientists to design the living world | $796M | 81/100 | |
2nd |  Syngenta 2000, Basel (Switzerland), Acquired | Developer of technologies and sustainable farming practices for farmers | - | 75/100 | |
3rd | Synthego 2012, Redwood City (United States), Acquired | Developer of CRISPR-engineered cell and gene therapies | $460M | 71/100 | |
4th |  Twist Bioscience 2013, San Francisco (United States), Public | Developer of a semiconductor-based DNA synthesis platform | $321M | 70/100 | |
5th | Codexis 2002, Redwood City (United States), Public | Developer of high-performance enzymes for drug discovery | $111M | 68/100 | |
6th |  AskBio 2001, Durham (United States), Acquired | Developer of AAV technologies for treating genetic and complex disorders | $235M | 68/100 | |
7th | Amyris 2003, Emeryville (United States), Public | Developer of renewable products for industrial solutions | $487M | 68/100 | |
8th | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
9th | Celmatix 2009, New York City (United States), Series C | Pioneering ovarian health therapeutics for women's unique biological needs | $24.9M | 66/100 | |
10th | Pendulum 2012, San Francisco (United States), Series C | Manufacturer of medical probiotics | $111M | 66/100 | |
86th |  Lorven Biologics 2015, Hyderabad (India), Seed | Developer of nutritional and pharma products | $46.6K | 40/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Lorven Biologics's competitors? Click here to see the top ones
Lorven Biologics's Latest cap tables and shareholding
Founders (largest shareholder) own 68.25%, Funds own 2.50% and Other People own 29.25%. The net worth of Lorven Biologics's founders is INR 5.47Cr as of Jul 16, 2017.
Shareholders Name | Post Round Holding % | Net worth | Cumulative Investment | Realised Returns | Unrealised Returns | Return Multiple |
|---|---|---|---|---|---|---|
Founder | 68.25% | 5.47Cr | 9295826 | 4142433 | 4490167 | 9887118 |
Fund | 2.50% | 20L | 54 | 75 | 52 | 34 |
76 | 41 | 62 | 18 | 11 | 13 | |
Other People | 29.25% | 2.34Cr | 8551624 | 2602655 | 6371097 | 9532974 |
Total | 100.00% | 8.01Cr | 6258559 | 1584960 | 6664941 | 2969345 |
To unlock detailed Cap Table of Lorven Biologics Sign up today!Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
DisclaimerView more details of Lorven Biologics's Shareholding
Lorven Biologics's Investments and acquisitions
Lorven Biologics has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Lorven Biologics
Explore our recently published companies
- Composite Engineers - Dehradun based, Unfunded company
- B D S H dro Treat Consultants Private Limited - India based, Unfunded company
- Shah & Shah - India based, Unfunded company
- Clevelandbridge - Saudi Arabia based, Unfunded company
- Woodlynn - New Zealand based, Unfunded company
- Mhd - New Zealand based, 1995 founded, Unfunded company
